Researchers from UC Irvine found that ophthalmic acid functions as a neurotransmitter, improving motor function in Parkinson’s models for over 20 hours. This discovery could lead to new treatments for Parkinson’s disease and challenges the traditional focus on dopamine as the sole regulator of movement.
1 Comment
TLDR:
Researchers from UC Irvine found that ophthalmic acid functions as a neurotransmitter, improving motor function in Parkinson’s models for over 20 hours. This discovery could lead to new treatments for Parkinson’s disease and challenges the traditional focus on dopamine as the sole regulator of movement.